Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-08-29 Marriott Tina President and COO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −6,000 464,000
2024-08-29 Gibson Christopher Chief Executive Officer Exercise or conversion +5,000 $2.48 $12K 757,656
2024-08-29 Gibson Christopher Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −5,000 287,500
2024-08-28 Gibson Christopher Chief Executive Officer Exercise or conversion +5,000 $2.48 $12K 752,656
2024-08-28 Gibson Christopher Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −5,000 292,500
2024-08-27 Gibson Christopher Chief Executive Officer Exercise or conversion +5,000 $2.48 $12K 747,656
2024-08-27 Gibson Christopher Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −5,000 297,500
2024-08-26 Gibson Christopher Chief Executive Officer Exercise or conversion +5,000 $2.48 $12K 742,656
2024-08-26 Gibson Christopher Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −5,000 302,500
2024-08-23 Gibson Christopher Chief Executive Officer Exercise or conversion +5,000 $2.48 $12K 737,656
2024-08-23 Gibson Christopher Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −5,000 307,500
2024-08-20 Borgeson Blake Director Sale 10b5-1 −11,447 $7.12 $82K 7,132,769
2024-08-15 Marriott Tina President and COO Shares withheld for taxes −14,319 $6.69 $96K 521,138
2024-08-15 Mauro David J Chief Medical Officer Shares withheld for taxes −14,146 $6.69 $95K 229,616
2024-08-15 Gibson Christopher Chief Executive Officer Shares withheld for taxes −26,082 $6.69 $174K 732,656
2024-08-15 Secora Michael Chief Financial Officer Shares withheld for taxes −11,962 $6.69 $80K 1,353,381
2024-08-14 Secora Michael Chief Financial Officer Exercise or conversion 10b5-1 +39,375 $2.22 $87K 1,380,343
2024-08-14 Secora Michael Chief Financial Officer Sale 10b5-1 −15,000 $6.35 $95K 1,365,343
2024-08-14 Secora Michael Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −39,375 573,885
2024-08-13 Secora Michael Chief Financial Officer Exercise or conversion 10b5-1 +39,375 $2.22 $87K 1,355,968

Page 16 of 41 · 805 trades